By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



4280 N. Campbell Avenue
Suite 214
Tucson  Arizona  85718  U.S.A.
Phone: 520-547-3440 Fax: 520-547-3456


Medical Device

Company News
CDISC And C-Path Announce Public Review Period For Duchenne Therapeutic Area Standard 6/13/2017 11:00:58 AM
C-Path’s Polycystic Kidney Disease Outcomes Consortium Secures European Medicines Agency Qualification Opinion For Enrichment Biomarker In ADPKD 11/16/2015 11:53:52 AM
C-Path Expands Partnerships to Speed Development of Critical New Drug Therapies 11/13/2008 9:21:10 AM
Rules-Based Medicine, Inc. Commercializes New Toxicity Biomarker Panel in Conjunction with FDA, European Medicines Evaluation Agency, C-Path and PSTC 6/30/2008 9:43:54 AM
C-Path Leads Novel Transatlantic Drug Safety Effort; Yields FDA/European Medicines Evaluation Agency Qualification of New Drug Tests for Kidney Safety 6/13/2008 9:40:10 AM
C-Path Awarded Grant to Continue Drug Safety Work 10/17/2007 12:49:06 PM
C-Path and Ventana Medical Systems, Inc. (VMSI) to Collaborate on Developing Standardized Evaluation for Companion Diagnostic Tests and Targeted Cancer Therapies 10/10/2007 8:00:01 AM